Overview

Comparison Of Different Doses Of Intrathecal Neostigmine In Prevention Of Post-Dural Puncture Headache

Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
We hypothesized that; intrathecal administration of neostgmine in spinal anesthesia may have a beneficial role in reduction of the incidence or severity of PDPH.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Cairo University
Treatments:
Neostigmine